Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07177157
PHASE1

The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients

Sponsor: Terry Ponich

View on ClinicalTrials.gov

Summary

The aim of this clinical trial is to gain a better understanding of the effect of Vitamin D supplementation on disease activity and overall health. The main questions it aims to answer are: 1. What proportion of IBD patients adhere to Vitamin D supplement recommendations over a 12-month period? 2. Is the ASK-12 Questionnaire valid in measuring adherence among IBD patients? 3. Does the severity of a patient's Crohn's disease effect overall adherence, over a 12-month period? 4. Does the severity of a patient's Ulcerative Colitis disease effect overall adherence, over a 12-month period? 5. Does Vitamin D supplementation affect the health-related Quality of Life for IBD patients? 6. Is 2,000 IU/Day an effective dose to sustain appropriate blood Vitamin D levels among previously Vitamin deficient IBD patients? Participants will: * Take 2000 IU of Vitamin D every day for the next 12 months * Complete 2 surveys, bloodwork and a fecal calprotectin test at the initial, visit, 6 month follow up and 12 month follow up

Official title: The Prospective Improved Vitamin D Study for IBD Patients Part 2 (The PIVD Study Part 2)

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2025-10

Completion Date

2027-03

Last Updated

2025-09-16

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (Cholecalciferol)

2000 IU of Vitamin D daily (1 pill)

Locations (1)

Victoria Hospital - London Health Sciences Centre

London, Ontario, Canada